Technical outlook: JNJ bullish scenario:
Technical outlook:
JNJ bullish scenario:
We have technical figure Triangle in US company Johnson & Johnson (JNJ) at daily chart. Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue. The Triangle has broken through the resistance line at 09/12/2020, if the price holds above this level we can have possible bullish price movement with forecast for the next 13 days towards 158.15 USD. Our stop loss order should be placed at 143.06 USD if we decide to enter this position.
Fundamentals:
- Mexico could order an additional 22 million doses of coronavirus vaccine from Johnson & Johnson’s Janssen unit under a memorandum of understanding signed this week, Deputy Health Minister Hugo Lopez-Gatell said on Tuesday.
JNJ bullish scenario:
We have technical figure Triangle in US company Johnson & Johnson (JNJ) at daily chart. Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue. The Triangle has broken through the resistance line at 09/12/2020, if the price holds above this level we can have possible bullish price movement with forecast for the next 13 days towards 158.15 USD. Our stop loss order should be placed at 143.06 USD if we decide to enter this position.
Fundamentals:
- Mexico could order an additional 22 million doses of coronavirus vaccine from Johnson & Johnson’s Janssen unit under a memorandum of understanding signed this week, Deputy Health Minister Hugo Lopez-Gatell said on Tuesday.
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.